Journal of Clinical Medicine · 2020 · 10 citations · 54 references
Life SciencesNeurobiologyNeuroscienceInflammationNeuroimmunologySignal TransductionCholinergic PharmacologyCholinergic SignalingImmune SignalingNeuroinflammationNeurotransmitter ReceptorsSynaptic TransmissionAdenosine Triphosphate ReleaseAgonists Of Cholinergic ReceptorsAmyloid Beta PeptidesCholinergic AgonistsInhibitory TransmissionInterleukin-1 Beta SignalingNicotinic Acetylcholine Receptor AgonismP2x7 Receptor Signaling
Amyloid-β peptide (Aβ1-42), the cleavage product of the evolutionary highly conserved amyloid precursor protein, presumably plays a pathogenic role in Alzheimer’s disease. Aβ1-42 can induce the secretion of the pro-inflammatory cytokine intereukin-1β (IL-1β) in immune cells within and out of the nervous system. Known interaction partners of Aβ1-42 are α7 nicotinic acetylcholine receptors (nAChRs). The physiological functions of Aβ1-42 are, however, not fully understood. Recently, we identified a cholinergic mechanism that controls monocytic release of IL-1β by canonical and non-canonical agonists of nAChRs containing subunits α7, α9, and/or α10. Here, we tested the hypothesis that Aβ1-42 modulates this inhibitory cholinergic mechanism. Lipopolysaccharide-primed monocytic U937 cells and human mononuclear leukocytes were stimulated with the P2X7 receptor agonist 2′(3′)-O-(4-benzoylbenzoyl)adenosine-5′-triphosphate triethylammonium salt (BzATP) in the presence or absence of nAChR agonists and Aβ1-42. IL-1β concentrations were measured in the supernatant. Aβ1-42 dose-dependently (IC50 = 2.54 µM) reversed the inhibitory effect of canonical and non-canonical nicotinic agonists on BzATP-mediated IL-1β-release by monocytic cells, whereas reverse Aβ42-1 was ineffective. In conclusion, we discovered a novel pro-inflammatory Aβ1-42 function that enables monocytic IL-1β release in the presence of nAChR agonists. These findings provide evidence for a novel physiological function of Aβ1-42 in the context of sterile systemic inflammation.
54
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Annett Halle, Veit Hornung, Gabor C. Petzold et al. · Nature Immunology · 2008 · 2.4K citations · Full text
Frederick J. Sheedy, Alena Grebe, Katey J. Rayner et al. · Nature Immunology · 2013 · 906 citations · Full text
Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils
Joseph El Khoury, Suzanne E. Hickman, Christian A. Thomas et al. · Nature · 1996 · 729 citations
Targeting C-reactive protein for the treatment of cardiovascular disease
Mark B. Pepys, Gideon M. Hirschfield, Glenys A. Tennent et al. · Nature · 2006 · 676 citations · Full text
Medicine, Cardiology, Pharmacology +14